Cargando…
Case report of apatinib mesylate treatment in rare advanced tracheal adenoid cystic carcinoma
A 57‐year‐old man was admitted to our department 10 years ago, diagnosed with tracheal adenoid cystic carcinoma. After discontinuing chemotherapy and radiotherapy, the disease recurred in December 2016. Apatinib mesylate (500 mg/day) was administered and computed tomography revealed that his symptom...
Autor principal: | Wang, Hongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668510/ https://www.ncbi.nlm.nih.gov/pubmed/28892250 http://dx.doi.org/10.1111/1759-7714.12506 |
Ejemplares similares
-
Laryngeal Preservation in Managing Advanced Tracheal Adenoid Cystic Carcinoma
por: Subramaniam, Thavakumar, et al.
Publicado: (2015) -
Syncope due to tracheal adenoid cystic carcinoma
por: Bots, Eva Marianne Theresa, et al.
Publicado: (2019) -
Tracheal adenoid cystic carcinoma masquerading asthma: A case report
por: Kokturk, Nurdan, et al.
Publicado: (2004) -
Combined surgery and radiotherapy as curative treatment for tracheal adenoid cystic carcinoma: a case report
por: Spinelli, Gian Paolo, et al.
Publicado: (2019) -
Rapid response to radiotherapy in unresectable tracheal adenoid cystic carcinoma: A case report
por: Wu, Qiang, et al.
Publicado: (2021)